This is a demo store. No orders will be fulfilled.

Bevacizumab (anti-VEGF)

    Grade & Purity:
  • Moligand™
  • ≥95%
  • ~25mg/ml(in buffer,PH6.2)
  • Isotype: Human IgG1
In stock
Item Number
B303060
Grouped product items
SKU Size
Availability
Price Qty
B303060-1mg
1mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$157.90
B303060-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$652.90

Basic Description

Product Name Bevacizumab (anti-VEGF)
Synonyms Anti-Human VEGF | Humanized Antibody | rhuMab VEGF, Avastin
Specifications & Purity Moligand™, ≥95%, ~25mg/ml(in buffer,PH6.2)
Grade Moligand™
Product Description

Bevacizumab is a humanized monoclonal antibody that binds to all VEGF-A with high affinity and specificity.

Product Properties

Concentration ~25mg/ml(in buffer,PH6.2)
Storage Temp Protected from light,Store at -20°C
Shipped In Ice chest + Ice pads
CAS 216974-75-3

Associated Targets(Human)

VEGFA Tclin Vascular endothelial growth factor A (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot Number Certificate Type Date Item
G2207121 Certificate of Analysis Apr 07, 2025 B303060
G2207118 Certificate of Analysis Apr 07, 2025 B303060
A2214365 Certificate of Analysis Nov 05, 2024 B303060
A2214366 Certificate of Analysis Nov 05, 2024 B303060
L2201633 Certificate of Analysis Aug 26, 2022 B303060
L2201667 Certificate of Analysis Aug 26, 2022 B303060

Citations of This Product

1. Wenjuan Huang, Liwen Wang, Ruhui Yang, Ronggui Hu, Qinxiang Zheng, Xingjie Zan.  (2022)  Combined delivery of small molecule and protein drugs as synergistic therapeutics for treating corneal neovascularization by a one-pot coassembly strategy.  Materials Today Bio,  17  (100456). 

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.